Skip to main content
Top
Published in: Pediatric Nephrology 7/2017

01-07-2017 | Original Article

Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits

Authors: Aadil Kakajiwala, Thomas Jemielita, John Z. Hughes, Kimberly Windt, Michelle Denburg, Stuart L. Goldstein, Benjamin Laskin

Published in: Pediatric Nephrology | Issue 7/2017

Login to get access

Abstract

Background

Clotting of continuous renal replacement therapy (CRRT) circuits leads to inadequate clearance, decreased ultrafiltration, and increased resource use. We identified factors associated with premature clotting of circuits during CRRT in children.

Methods

In a retrospective cohort of 26 children (median age 11.8 years) receiving 79 CRRT circuits (51 heparin, 22 citrate, 6 using no anticoagulation), we captured hourly pressure, flow, and fluid removal rates along with all activated clotting time (ACT) and circuit ionized calcium measurements. Cox and logistic regression models were used to examine factors associated with premature circuit clotting before the scheduled 3-day circuit change.

Results

Of the 79 circuits, 51 (64.6%) underwent unplanned filter change due to filter clotting (median duration 18.25 h, interquartile range [IQR] 9.25, 33.5 h), and 28 (35.4%) underwent scheduled change (median duration 66 h, IQR 61.00, 69.00 h). Patient age, catheter size and location, blood flow rate, and the percentage of pre-filter replacement fluid were not associated with premature clotting. Heparin circuits were less likely than citrate circuits to clot prematurely. Each 1-mmHg increase in the transmembrane or filter pressure was independently associated with a 1.5% (95% confidence interval [CI] 1.0–2.0%) and 1.5% (95% CI 1.0–2.0%) higher risk of clotting, respectively. Higher ACTs were associated with lower transmembrane (p = 0.03) and filter (p < 0.001) pressures.

Conclusions

The majority of circuits in our cohort were subject to unplanned filter changes. Elevated transmembrane and filter pressures were associated with clotting. Our results suggest that maintaining higher ACT may decrease the risk of circuit clotting. Larger studies are needed to examine other factors that may prolong the lifespan of the CRRT circuit in this high-risk population.
Literature
1.
go back to reference Fortenberry JD, Paden ML, Goldstein SL (2013) Acute kidney injury in children: an update on diagnosis and treatment. Pediatric Clin North Am 60(3):669–688CrossRef Fortenberry JD, Paden ML, Goldstein SL (2013) Acute kidney injury in children: an update on diagnosis and treatment. Pediatric Clin North Am 60(3):669–688CrossRef
2.
go back to reference Sutherland SM, Alexander SR (2012) Continuous renal replacement therapy in children. Pediatr Nephrol 27:2007–2016CrossRefPubMed Sutherland SM, Alexander SR (2012) Continuous renal replacement therapy in children. Pediatr Nephrol 27:2007–2016CrossRefPubMed
3.
go back to reference Uchino S, Nigel F, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: the incidence and impact of circuit downtime on uremic control during continuous vena-venous haemofiltration. Intensive Care Med 29:575–578CrossRefPubMed Uchino S, Nigel F, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: the incidence and impact of circuit downtime on uremic control during continuous vena-venous haemofiltration. Intensive Care Med 29:575–578CrossRefPubMed
4.
go back to reference Srisawats N, Lawsin L, Uchino S, Bellomo R, Kellum JA, BEST Kidney Investigators (2010) Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care 14(2):R46CrossRef Srisawats N, Lawsin L, Uchino S, Bellomo R, Kellum JA, BEST Kidney Investigators (2010) Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care 14(2):R46CrossRef
5.
go back to reference Baldwin I, Bellomo R, Koch B (2000) Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Med 26:1694–1697CrossRef Baldwin I, Bellomo R, Koch B (2000) Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Med 26:1694–1697CrossRef
6.
go back to reference Holt AW, Bierer P, Bersten AD, Bury LK, Vedig AE (1996) Continuous renal replacement therapy in critically ill patients: monitoring circuit function. Anaesth Intensive Care 24(4):423–429PubMed Holt AW, Bierer P, Bersten AD, Bury LK, Vedig AE (1996) Continuous renal replacement therapy in critically ill patients: monitoring circuit function. Anaesth Intensive Care 24(4):423–429PubMed
7.
8.
go back to reference Brophy PD, Somers MJ, Baum M, Symins JM, McAfee N, Firtenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL (2005) Multi-center evaluation of anticoagulation in patients receiving renal replacement therapy (CRRT). Nephrol Dail Transplant 20:1416–1421CrossRef Brophy PD, Somers MJ, Baum M, Symins JM, McAfee N, Firtenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL (2005) Multi-center evaluation of anticoagulation in patients receiving renal replacement therapy (CRRT). Nephrol Dail Transplant 20:1416–1421CrossRef
9.
go back to reference Soltysiak J, Warzywoda A, Kocinski B, Ostalska-Nowicka D, Benedyk A, Silska-Dittmar M, Zachwieja J (2014) Citrate anticoagulation for continuous renal replacement therapy in small children. Pediatr Nephrol 29:469–475CrossRefPubMed Soltysiak J, Warzywoda A, Kocinski B, Ostalska-Nowicka D, Benedyk A, Silska-Dittmar M, Zachwieja J (2014) Citrate anticoagulation for continuous renal replacement therapy in small children. Pediatr Nephrol 29:469–475CrossRefPubMed
10.
go back to reference Fernandez SN, Santiago MJ, Lopez-Herce J, Garcia M, Del Castillo J, Alcaraz AJ, Bellon JM (2014) Citrate anticoagulation for CRRT in children: comparison with heparin. Biomed Res Int 2014:786301PubMedCentralPubMed Fernandez SN, Santiago MJ, Lopez-Herce J, Garcia M, Del Castillo J, Alcaraz AJ, Bellon JM (2014) Citrate anticoagulation for CRRT in children: comparison with heparin. Biomed Res Int 2014:786301PubMedCentralPubMed
11.
go back to reference Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, Saudan P (2015) Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care 19:91CrossRefPubMedCentralPubMed Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, Saudan P (2015) Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care 19:91CrossRefPubMedCentralPubMed
12.
go back to reference Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30(2):260–265CrossRefPubMed Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30(2):260–265CrossRefPubMed
13.
go back to reference Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Pre-dilution vs post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 94:c94–c98CrossRefPubMed Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Pre-dilution vs post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 94:c94–c98CrossRefPubMed
14.
go back to reference Goonasekera CD, Wang J, Bunchman TE, Deep A (2015) Factors affecting circuit life during continuous renal replacement therapy in children with liver failure. Ther Apher Dial 19(1):16–22CrossRefPubMed Goonasekera CD, Wang J, Bunchman TE, Deep A (2015) Factors affecting circuit life during continuous renal replacement therapy in children with liver failure. Ther Apher Dial 19(1):16–22CrossRefPubMed
15.
go back to reference Sutherland SM, Goldstein SL, Alexander SR (2014) The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: a critical appraisal. Pediatr Nephrol 29:2069–2076CrossRefPubMed Sutherland SM, Goldstein SL, Alexander SR (2014) The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: a critical appraisal. Pediatr Nephrol 29:2069–2076CrossRefPubMed
16.
go back to reference Hackbarth R, Bunchman TE, Chua AN, Somers MJ, Baum M, Symons JM, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Alexander SR, Mahan JD, McBryde KD, Benfield MR, Goldstein SL (2007) The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs 30:1116–1121PubMed Hackbarth R, Bunchman TE, Chua AN, Somers MJ, Baum M, Symons JM, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Alexander SR, Mahan JD, McBryde KD, Benfield MR, Goldstein SL (2007) The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs 30:1116–1121PubMed
17.
go back to reference del Castillo J, Lopez-Herce J, Cidoncha E, Urbano J, Mencia S, Santiago MJ, Bellon JM (2008) Circuit life span in critically ill children on continuous renal replacement treatment: a perspective observational evaluation study. Crit Care 12:R93CrossRefPubMedCentralPubMed del Castillo J, Lopez-Herce J, Cidoncha E, Urbano J, Mencia S, Santiago MJ, Bellon JM (2008) Circuit life span in critically ill children on continuous renal replacement treatment: a perspective observational evaluation study. Crit Care 12:R93CrossRefPubMedCentralPubMed
18.
go back to reference Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2(4):732–738CrossRefPubMed Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2(4):732–738CrossRefPubMed
19.
go back to reference Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42(6):1248–1252CrossRefPubMed Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42(6):1248–1252CrossRefPubMed
20.
go back to reference Friedman J (2001) Greedy function approximation: a Gradient Boosting Machine. Ann Stat 29(5):1189–1232CrossRef Friedman J (2001) Greedy function approximation: a Gradient Boosting Machine. Ann Stat 29(5):1189–1232CrossRef
22.
go back to reference Tolwani A (2012) Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 367:2505–2514CrossRefPubMed Tolwani A (2012) Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 367:2505–2514CrossRefPubMed
23.
go back to reference Baldwin I, Bellomo R (2004) Relationship between blood flow, access catheter and circuit failure during CRRT: a practical review. Contrib Nephrol 144:203–213CrossRefPubMed Baldwin I, Bellomo R (2004) Relationship between blood flow, access catheter and circuit failure during CRRT: a practical review. Contrib Nephrol 144:203–213CrossRefPubMed
24.
go back to reference Ramesh Prasad GV, Palevsky PM, Burr R, Lesko JM, Gupta B, Greenberg A (2000) Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial. Clin Nephrol 53(1):55–60PubMed Ramesh Prasad GV, Palevsky PM, Burr R, Lesko JM, Gupta B, Greenberg A (2000) Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial. Clin Nephrol 53(1):55–60PubMed
25.
go back to reference Ejaz AA, Komorski RM, Ellis GH, Munjal S (2007) Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration. Nurs Crit Care 2(2):81–85CrossRef Ejaz AA, Komorski RM, Ellis GH, Munjal S (2007) Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration. Nurs Crit Care 2(2):81–85CrossRef
Metadata
Title
Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits
Authors
Aadil Kakajiwala
Thomas Jemielita
John Z. Hughes
Kimberly Windt
Michelle Denburg
Stuart L. Goldstein
Benjamin Laskin
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 7/2017
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3601-z

Other articles of this Issue 7/2017

Pediatric Nephrology 7/2017 Go to the issue